KCT0009395招募中Unknown
Patient preference study using discrete choice experiment for Multiple Myeloma patients in Korea
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 19(Year) 至 o Limit（—）
- 性别
- All
入选标准
- •1. Individuals aged 18 and above.
- •2. Those who can read and understand documents written in Korean.
- •3. Patients who have been diagnosed with multiple myeloma by a healthcare professional and fall into one of the following treatment stages: newly diagnosed and scheduled for treatment, undergoing 1st or 2nd line treatment, or in a relevant condition after treatment. Recurrent/resistant patients requiring additional treatment for multiple myeloma after the 3rd line of treatment.
- •4.Must sign an Informed Consent Form (ICF) allowing data collection and confirmation of evidence based on local requirements.
- •1. Individuals aged 18 and above.
- •2. Those who can read and understand documents written in Korean.
- •3. Individuals providing care for a multiple myeloma patient and well-informed about the treatment options for the condition.
- •The survey includes questions about whether the caregiver currently lives with the patient or is the primary family member providing financial support to the patient.
- •4. Must sign an Informed Consent Form (ICF) allowing data collection and confirmation of evidence based on local requirements.
- •1. Those who can read and understand documents written in Korean.
- •2. Individuals with more than 3 years of experience in treating multiple myeloma patients.
- •3. Those who diagnose/monitor more than 50 multiple myeloma patients annually.
- •4. Individuals with over 3 years of experience discussing multiple myeloma treatment and management with other healthcare professionals such as hematologists/oncologists, 'multiple myeloma specialist' (key opinion leaders)/conference speakers.
- •5. Must agree to participate in the study before the online survey.
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
不适用
Randomized cross-over study of patient preference for oral or intravenous vinorelbine in the treatment of advanced NSCLC. A phase IV studyEUCTR2012-003544-68-ITISTITUTO SCIENTIFICO ROMAGNOLO PER LO STUDIO E LA CURA DEI TUMORI
尚未招募
Unknown
A study to look at the benefit of a radical treatment approach in advanced head and neck cancer as across a palliative approach.CTRI/2023/10/058737Varian Medical Systems Inc
招募中
不适用
Patient preference to guide AFO prescriptioNL-OMON28247Sint Maartenskliniek25
进行中（未招募）
不适用
Measuring patient preferences for the treatment of rectal cancerRectal cancerMalignant neoplasm of rectumCancerISRCTN17870623niversity of Manchester600
已完成
不适用
A pilot patient preference randomised controlled trial of admission to a women's crisis house compared with psychiatric hospital admissioAny psychiatric disorder requiring admission to hospital or women's crisis house.Mental and Behavioural DisordersPsychiatric disordersISRCTN20804014Institute of Psychiatry (UK)75